2 models fit Microchip Technology Incorporated Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionMicrochip Technology Incorporated Common Stock (MCHP)
Fair value (2 models)
$34.04
ACCE price target
$82.00
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $35.13 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 16 Oct 2026, 00:00 CEST; previously $65.00 since 19 Apr 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $74.05 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
117.5% above
-54.0% to fair value
ACCE score
50
out of 100
Analysts
77% buy
26 covering
P/E
108.9x
forward 16.1x
1-year return
+13.8%
Dividend yield
2.44%
Microchip Technology Incorporated Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Microchip designs and sells microcontrollers, analog and mixed-signal chips, and FPGAs that go into industrial equipment, automotive systems, aerospace and data center hardware, with a long catalogue of products sold through distributors. The business benefits from sticky design-ins: once an engineer builds a Microchip part into a product with a multi-year life, switching costs are high, which supports its 60.2% gross margin. Revenue growth of 38.0% is strong, and the forward P/E of 20.5 against a trailing 109.2 suggests earnings are recovering faster than the trailing figures show, though the 7.2% ROE and 24.0% operating margin mean the balance sheet and cycle exposure still deserve scrutiny. The score of 54/100 says this is not yet a clear-cut case, so the question for a PM is whether the earnings recovery and the 38.0% top-line growth are durable enough to justify a closer look at the cycle position and inventory trends.